Thursday, August 22, 2019

Biocon#39;s Malaysia insulins facility gets approval of European drug regulator

Biocon#39;s Malaysia insulins facility gets approval of European drug regulator The EMA certification will help Biocon secure its supply chain as well as expand sales of its insulin products in European Union nations

from Moneycontrol Business News https://ift.tt/2zhCeYt

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...